Variant report
Variant | esv3374497 |
---|---|
Chromosome Location | chr8:3628769-3631317 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs58171140 | chr8:3628772-3628773 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116387255 | chr8:3628788-3628789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200518614 | chr8:3628806-3628807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146506794 | chr8:3628845-3628846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2407039 | chr8:3628864-3628865 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs552967846 | chr8:3628870-3628871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577889780 | chr8:3628880-3628881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577300294 | chr8:3628893-3628894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545322702 | chr8:3628909-3628910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563525811 | chr8:3628913-3628914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573145392 | chr8:3628917-3628918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531053278 | chr8:3628920-3628921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138741642 | chr8:3628949-3628950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376182968 | chr8:3628953-3628954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199796631 | chr8:3628960-3628961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs386721112 | chr8:3628962-3628963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113338150 | chr8:3628963-3628964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201103516 | chr8:3628964-3628965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2897574 | chr8:3628979-3628980 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs576030067 | chr8:3628981-3628982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187955341 | chr8:3628986-3628987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149349385 | chr8:3628988-3628989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569820888 | chr8:3629000-3629001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536802146 | chr8:3629011-3629012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572271441 | chr8:3629016-3629017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570180670 | chr8:3629035-3629036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567622023 | chr8:3629056-3629057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544782842 | chr8:3629061-3629062 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534815818 | chr8:3629064-3629065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552928834 | chr8:3629093-3629094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77286236 | chr8:3629095-3629096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs55663067 | chr8:3629111-3629112 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs192408490 | chr8:3629140-3629141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78113756 | chr8:3629153-3629154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368109083 | chr8:3629155-3629156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559442630 | chr8:3629199-3629200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs80111992 | chr8:3629201-3629202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528025562 | chr8:3629209-3629210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148169357 | chr8:3629214-3629215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143025491 | chr8:3629233-3629234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2720771 | chr8:3629243-3629244 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs532997343 | chr8:3629244-3629245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146128718 | chr8:3629293-3629294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs76567431 | chr8:3629299-3629300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530851965 | chr8:3629315-3629316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548879798 | chr8:3629320-3629321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184955479 | chr8:3629339-3629340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534778723 | chr8:3629347-3629348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187370284 | chr8:3629348-3629349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74338343 | chr8:3629353-3629354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3625000-3636400 | Weak transcription | Fetal Brain Male | brain |
2 | chr8:3626800-3631400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr8:3628800-3629600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:3629600-3633400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:3631200-3631600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr8:3631200-3631600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr8:3631200-3632000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |